Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by longterm56on Feb 04, 2020 8:30pm
100 Views
Post# 30643051

RE:question re DR G

RE:question re DR G
palinc2000 wrote: From the PR
"The MGH, through Dr. Steven Grinspoon, who is chief of the hospital’s Metabolism Unit, has agreed to assist Theratechnologies in connection with the Study design, selection of optimal patient population, dosing, Study duration and other safety matters and to participate, if need be, in regulatory meetings with the United States Food and Drug Administration (FDA) or the European Medicines Agency (EMA)"

My primary language is not Engish but how can anyone infer from the abobe that Dr G was already in the loop with regards to the items above that he will assist?
It would have been so simple if true to write that Dr G has already  been involved in every step of the regulatory process and this agreement materializes this relation for the long term .....That alone would have indicated that things were going well 


Then let me help.  "Grinspoon ... has agreed to assist Theratechnologies in connection with the Study design" ...

 "has agreed to assist" is in the past tense, it could have been yesterday or 6 months ago. It does not convey whether he was/is/will assist ... it conveys that he agreed to assist.  Intepreting this to say he has yet to assist is wrong. This statement is totally consistent with Grinspoon helping them last year. 


It's really, really, really good news!

   -LT


Bullboard Posts